/AUGX

AUGX Stock - Augmedix, Inc.

Q: What is the analyst price target for AUGX?

Analyst price target information is not currently available for AUGX.

Q: What is AUGX's market cap?

Market capitalization information is not currently available for AUGX.

Healthcare|Medical - Healthcare Information Services|NASDAQ

$2.35-0.21%

$0.01 (-0.21%) • Oct 1

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+63.3%upside

Target: $3.83

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for AUGX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.19

52W High$6.25

52W Low$0.73

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$44.85M	$30.93M	$22.16M	$16.48M	$14.11M
Gross Profit	$21.53M	$13.95M	$10.01M	$6.79M	$4.68M
Gross Margin	48.0%	45.1%	45.1%	41.2%	33.2%
Operating Income	$-18,779,000	$-22,371,000	$-17,938,000	$-13,693,000	$-16,742,709
Net Income	$-19,171,000	$-26,527,000	$-17,160,000	$-14,737,000	$-22,361,163
Net Margin	-42.7%	-85.8%	-77.4%	-89.4%	-158.5%
EPS	$-0.44	$-0.71	$-0.59	$-0.56	$-26.89

Company Overview

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

25%

Hold / Neutral

75%

Sell / Underperform

Analyst Consensus🔴 Bearish

1 Bullish3 Neutral/Bearish

Price Targets

Average Target

↑ 63.6% Upside

Now

Low

Average

High

Based on 4 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
July 22nd 2024	Lake Street	Downgrade	Hold	-
July 22nd 2024	B. Riley Securities	Downgrade	Neutral	$2.35← $3
May 14th 2024	Maxim Group	Downgrade	Hold	-
May 14th 2024	Evercore ISI	Downgrade	In-line	$1.5← $5
April 3rd 2024	B. Riley Securities	Resumed	Buy	$5.5
December 15th 2023	Evercore ISI	Initiation	In-line	$6

Earnings History & Surprises

AUGX

Beat Rate

50%

Last 14 quarters

Avg Surprise

+1.4%

EPS vs Estimate

Beats / Misses

7/5

2 met exactly

Latest EPS

$-0.10

Q4 2024

EPS Surprise History

Q1 23

0.0%

$-0.15vs$-0.15

Q2 23

+6.7%

$-0.14vs$-0.15

Q3 23

+7.7%

$-0.12vs$-0.13

Q4 23

+16.7%

$-0.10vs$-0.12

Q1 24

+10.0%

$-0.09vs$-0.10

Q2 24

0.0%

$-0.12vs$-0.12

Q3 24

-33.3%

$-0.16vs$-0.12

Q4 24

+33.3%

$-0.10vs$-0.15

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2024	Nov 4, 2024	$-0.15	$-0.10	+33.3%	✓ BEAT
Q3 2024	Aug 12, 2024	$-0.12	$-0.16	-33.3%	✗ MISS
Q2 2024	May 13, 2024	$-0.12	$-0.12	0.0%	= MET
Q1 2024	Mar 18, 2024	$-0.10	$-0.09	+10.0%	✓ BEAT
Q4 2023	Nov 6, 2023	$-0.12	$-0.10	+16.7%	✓ BEAT
Q3 2023	Aug 7, 2023	$-0.13	$-0.12	+7.7%	✓ BEAT
Q2 2023	May 12, 2023	$-0.15	$-0.14	+6.7%	✓ BEAT
Q1 2023	Mar 27, 2023	$-0.15	$-0.15	0.0%	= MET
Q4 2022	Nov 18, 2022	$-0.17	$-0.15	+11.8%	✓ BEAT
Q3 2022	Aug 11, 2022	$-0.15	$-0.17	-13.3%	✗ MISS
Q2 2022	May 12, 2022	$-0.14	$-0.16	-14.3%	✗ MISS
Q1 2022	Mar 30, 2022	$-0.15	$-0.16	-6.7%	✗ MISS
Q4 2021	Nov 9, 2021	$-0.10	$-0.11	-10.0%	✗ MISS
Q3 2021	Aug 10, 2021	$-0.19	$-0.17	+10.5%	✓ BEAT
Q2 2021	May 13, 2021	—	$-0.18	—	—
Q1 2021	Mar 31, 2021	—	$-0.14	—	—
Q3 2020	Sep 30, 2020	—	$-0.15	—	—
Q3 2020	Aug 13, 2020	—	$-0.11	—	—
Q2 2020	May 15, 2020	—	$-0.18	—	—
Q1 2020	Mar 30, 2020	—	$-1.86	—	—

Frequently Asked Questions about AUGX

What is AUGX's current stock price?

Augmedix, Inc. (AUGX) is currently trading at $2.35 per share. The stock has moved -0.21% today.

What is the analyst price target for AUGX?

The average analyst price target for AUGX is $3.83, based on 1 analyst.

What sector is Augmedix, Inc. in?

Augmedix, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.

What is AUGX's market cap?

Augmedix, Inc. has a market capitalization of $0.12 billion, making it a small-cap company.

Does AUGX pay dividends?

No, Augmedix, Inc. does not currently pay a dividend to shareholders.